These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 34440421)
1. Advances in Genetic and Molecular Understanding of Alzheimer's Disease. Ibanez L; Cruchaga C; Fernández MV Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440421 [TBL] [Abstract][Full Text] [Related]
2. A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease. Kashif M; Sivaprakasam P; Vijendra P; Waseem M; Pandurangan AK Curr Pharm Des; 2023; 29(43):3428-3441. PubMed ID: 38038007 [TBL] [Abstract][Full Text] [Related]
3. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative. Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ; Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505 [TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Imaging of Preclinical, Sporadic, and Autosomal Dominant Alzheimer's Disease. Buckley RF Neurotherapeutics; 2021 Apr; 18(2):709-727. PubMed ID: 33782864 [TBL] [Abstract][Full Text] [Related]
5. Novel Targets for Alzheimer's Disease: A View Beyond Amyloid. Ray WJ; Buggia-Prevot V Annu Rev Med; 2021 Jan; 72():15-28. PubMed ID: 32867590 [TBL] [Abstract][Full Text] [Related]
6. Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-β pathology. Suárez-Calvet M; Morenas-Rodríguez E; Kleinberger G; Schlepckow K; Araque Caballero MÁ; Franzmeier N; Capell A; Fellerer K; Nuscher B; Eren E; Levin J; Deming Y; Piccio L; Karch CM; Cruchaga C; Shaw LM; Trojanowski JQ; Weiner M; Ewers M; Haass C; Mol Neurodegener; 2019 Jan; 14(1):1. PubMed ID: 30630532 [TBL] [Abstract][Full Text] [Related]
7. Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles. Singh AK; Mishra G; Maurya A; Awasthi R; Kumari K; Thakur A; Rai A; Rai GK; Sharma B; Kulkarni GT; Singh SK Curr Alzheimer Res; 2019; 16(13):1216-1229. PubMed ID: 31481003 [TBL] [Abstract][Full Text] [Related]
8. Computational Causal Modeling of the Dynamic Biomarker Cascade in Alzheimer's Disease. Petrella JR; Hao W; Rao A; Doraiswamy PM Comput Math Methods Med; 2019; 2019():6216530. PubMed ID: 30863455 [TBL] [Abstract][Full Text] [Related]
13. Integrated biology approach reveals molecular and pathological interactions among Alzheimer's Aβ42, Tau, TREM2, and TYROBP in Drosophila models. Sekiya M; Wang M; Fujisaki N; Sakakibara Y; Quan X; Ehrlich ME; De Jager PL; Bennett DA; Schadt EE; Gandy S; Ando K; Zhang B; Iijima KM Genome Med; 2018 Mar; 10(1):26. PubMed ID: 29598827 [TBL] [Abstract][Full Text] [Related]
14. Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes. Pluta R; Jabłoński M; Ułamek-Kozioł M; Kocki J; Brzozowska J; Januszewski S; Furmaga-Jabłońska W; Bogucka-Kocka A; Maciejewski R; Czuczwar SJ Mol Neurobiol; 2013 Dec; 48(3):500-15. PubMed ID: 23519520 [TBL] [Abstract][Full Text] [Related]
15. A review of the advances, insights, and prospects of gene therapy for Alzheimer's disease: A novel target for therapeutic medicine. Ataei B; Hokmabadi M; Asadi S; Asadifard E; Aghaei Zarch SM; Najafi S; Bagheri-Mohammadi S Gene; 2024 Jun; 912():148368. PubMed ID: 38485038 [TBL] [Abstract][Full Text] [Related]
16. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models. Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018 [TBL] [Abstract][Full Text] [Related]
17. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models. Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S Elife; 2020 Jun; 9():. PubMed ID: 32510331 [TBL] [Abstract][Full Text] [Related]
18. Targeting Abeta and tau in Alzheimer's disease, an early interim report. Golde TE; Petrucelli L; Lewis J Exp Neurol; 2010 Jun; 223(2):252-66. PubMed ID: 19716367 [TBL] [Abstract][Full Text] [Related]
19. Status and future directions of clinical trials in Alzheimer's disease. Plascencia-Villa G; Perry G Int Rev Neurobiol; 2020; 154():3-50. PubMed ID: 32739008 [TBL] [Abstract][Full Text] [Related]
20. Amyloid-β and Tau at the Crossroads of Alzheimer's Disease. Gallardo G; Holtzman DM Adv Exp Med Biol; 2019; 1184():187-203. PubMed ID: 32096039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]